Terms: = Liver cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2 AND Treatment
10 results:
1. Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.
Loos NHC; Ferreira Martins ML; Rijmers J; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
Mol Pharm; 2024 Apr; 21(4):1952-1964. PubMed ID: 38423793
[TBL] [Abstract] [Full Text] [Related]
2. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Pretta A; Ziranu P; Giampieri R; Donisi C; Cimbro E; Spanu D; Lai E; Pecci F; Balconi F; Lupi A; Pozzari M; Persano M; Murgia S; Pusceddu V; Puzzoni M; Berardi R; Scartozzi M
Dig Liver Dis; 2023 May; 55(5):655-660. PubMed ID: 36513569
[TBL] [Abstract] [Full Text] [Related]
3. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
[TBL] [Abstract] [Full Text] [Related]
4. Impact of sustained virological response to chronic hepatitic C antiviral therapy on new onset diabetes mellitus type 2 after controlling for metabolic syndrome.
Pandya P; Pant C; Taylor R; Oni O
J Investig Med; 2017 Apr; 65(4):765-771. PubMed ID: 28232517
[TBL] [Abstract] [Full Text] [Related]
5. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.
Screen M; Jonson PH; Raheem O; Palmio J; Laaksonen R; Lehtimäki T; Sirito M; Krahe R; Hackman P; Udd B
Am J Pathol; 2014 Aug; 184(8):2322-32. PubMed ID: 24907641
[TBL] [Abstract] [Full Text] [Related]
6. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.
Donadon V; Balbi M; Valent F; Avogaro A
World J Gastroenterol; 2010 Jun; 16(24):3025-32. PubMed ID: 20572306
[TBL] [Abstract] [Full Text] [Related]
7. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract] [Full Text] [Related]
8. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.
Bavirti S; Tayek JA
Metabolism; 2003 Apr; 52(4):407-12. PubMed ID: 12701050
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
Fu L; Cheng YC
Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
[TBL] [Abstract] [Full Text] [Related]
10. [Spreading patterns of hilar bile duct cancer].
Nagakawa T; Kitagawa H; Kayahara M; Ohta T; Konishi I
Nihon Geka Gakkai Zasshi; 2000 May; 101(5):399-403. PubMed ID: 10884987
[TBL] [Abstract] [Full Text] [Related]
